Laser Efficiency on Metabolic Parameters
Effect of Non-invasive on Lipid Metabolism and Renal Out Comes in Metabolic Syndrome
1 other identifier
observational
40
1 country
1
Brief Summary
Non-invasive laser therapy is laser blood irradiation improves many metabolic parameters. So, this study aims to assess the impact of Non-invasive laser therapy on lipid metabolism and renal out comes
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2023
CompletedFirst Submitted
Initial submission to the registry
December 11, 2023
CompletedFirst Posted
Study publicly available on registry
January 5, 2024
CompletedJanuary 5, 2024
December 1, 2023
3 months
December 11, 2023
December 21, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
lipid profile change
laboratorial measurement of lipid in one mg/dl of blood
12 weeks following end of treatment
glomerular function range change
laboratorial measurement of glomerular function range in one ml of blood/1minute/1.73m2
12 weeks following end of treatment
creatinine change
laboratorial measurement of creatinine one mg/DL of blood
12 weeks following end of treatment
Study Arms (2)
study group
wear the laser watch on wrist 3times/weak up to 30 minute for 12 weeks ,
control group
taking advises only
Interventions
(diode laser, continuous output, in skin contact mode, 0.005W,0.2cm,beam spot area 0.03cm2, 288j/cm ,1800s) in the morning session, we measured lipid profile and kidney function before and after treatment to measure improvement
Eligibility Criteria
the study population selected from out patient of Berket El-haje medical center suffering from metabolic syndrome
You may qualify if:
- The patients have Metabolic syndrome, started more than one year ago.
- BMI ranged 30- 35Kg/m2.
- They are on medical therapy for more than one year.
- Clinically stable.
You may not qualify if:
- taking specific drugs uncontrolled diseases
- cardiovascular instability
- sever e autonomic neuropathy
- infection wound,
- burn, allergy or another external injury
- hypothyroidism
- hemorrhagic disorders
- history of cancer
- pregnant women,
- mental illness as schizophrenia or dementia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Toka
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer cardiovascular, Respiratory disorder and geriatric department,
Study Record Dates
First Submitted
December 11, 2023
First Posted
January 5, 2024
Study Start
April 10, 2023
Primary Completion
June 30, 2023
Study Completion
October 10, 2023
Last Updated
January 5, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share